Evidence map›Paper›PMID 26319414›Full record

ArticleClinical immunology (Orlando, Fla.)2015

Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation.

Brian R Lawson, Rosana Gonzalez-Quintial, Theodoros Eleftheriadis, Michael A Farrar, Stephen D Miller, Karsten Sauer, Dorian B McGavern, Dwight H Kono, Roberto Baccala, Argyrios N Theofilopoulos

Open access · greenAbstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. IL-7Rα on CD4Journal of neuroinflammation · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Immunomodulation and Regenerative Capacity of MSCs for Long-COVID.International journal of molecular sciences · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Brian R LawsonThe Scripps Research Institute, Department of Immunology and Microbial Science, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Rosana Gonzalez-QuintialThe Scripps Research Institute, Department of Immunology and Microbial Science, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Theodoros EleftheriadisThe Scripps Research Institute, Department of Immunology and Microbial Science, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Michael A FarrarUniversity of Minnesota, Department of Laboratory Medicine and Pathology, 2-116 MBB, 2101 6th Street SE, Minneapolis, MN 55414, USA.
Stephen D MillerNorthwestern University Medical School, Department of Microbiology-Immunology, 303 E Chicago Avenue, Chicago, IL 60611, USA.
Karsten SauerThe Scripps Research Institute, Department of Immunology and Microbial Science, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Dorian B McGavernNational Institute of Neurological Disorders and Stroke, The National Institutes of Health, Bethesda, MD 20892, USA.
Dwight H KonoThe Scripps Research Institute, Department of Immunology and Microbial Science, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Roberto BaccalaThe Scripps Research Institute, Department of Immunology and Microbial Science, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Argyrios N TheofilopoulosThe Scripps Research Institute, Department of Immunology and Microbial Science, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. Electronic address: argyrio@scripps.edu.
Scripps Research Institute · USNational Institutes of Health · USNorthwestern University · USUniversity of Minnesota · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1998 to 2026
$100.4M
Mechanisms Underlying Clearance of the Persistently Infected CNSZIANS003111 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI MCGAVERN, DORIAN · 2009 to 2025
$33.0M
IMMUNOREGULATION AND PATHOLOGY OF CHRONIC-RELAPSING EAER01NS026543 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MILLER, STEPHEN D · 1988 to 2016
$5.0M
IL-7 Biology and Role in Systemic AutoimmunityR01AR065919 · NIAMS · SCRIPPS RESEARCH INSTITUTE, THE · PI THEOFILOPOULOS, ARGYRIOS N · 2014 to 2018
$2.1M
The Role of Transmethylation Reactions in AutoimmunityR01AI076396 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI LAWSON, BRIAN · 2009 to 2012
$1.9M
Genetics of Autoimmune Hemolytic AnemiaR01HL114408 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI KONO, DWIGHT H · 2013 to 2016
$1.9M
NCI NIH HHS P30 CA077598NHLBI NIH HHS R01 HL114408NIAID NIH HHS R01 AI076396NIAMS NIH HHS AR065919NIAMS NIH HHS R01 AR065919NINDS NIH HHS R01 NS026543
6 · The paper itself

Abstract

IL-7 is known to be vital for T cell homeostasis but has previously been presumed to be dispensable for TCR-induced activation. Here, we show that IL-7 is critical for the initial activation of CD4(+) T cells in that it provides some of the necessary early signaling components, such as activated STAT5 and Akt. Accordingly, short-term in vivo IL-7Rα blockade inhibited the activation and expansion of autoantigen-specific CD4(+) T cells and, when used to treat experimental autoimmune encephalomyelitis (EAE), prevented and ameliorated disease. Our studies demonstrate that IL-7 signaling is a prerequisite for optimal CD4(+) T cell activation and that IL-7R antagonism may be effective in treating CD4(+) T cell-mediated neuroinflammation and other autoimmune inflammatory conditions.

Indexed as

AnimalsCD4-Positive T-LymphocytesCell ProliferationCytokinesEncephalomyelitis, Autoimmune, ExperimentalFlow CytometryHumansInterleukin-7Lymphocyte ActivationMice, Inbred C57BLMice, Inbred StrainsMice, KnockoutMice, TransgenicPhosphorylationProto-Oncogene Proteins c-aktReceptors, Antigen, T-CellCytokinesInterleukin-7interleukin-7 receptor, alpha chainProto-Oncogene Proteins c-aktReceptors, Antigen, T-CellReceptors, Interleukin-7STAT2 Transcription FactorEAEIL-7Signaling pathwaysT cells

Identifiers

PMID26319414
PMCPMC4658267
OpenAlexW1916318763

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.